Jefferies Financial Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82M Sell
30,500
-60,500
-66% -$6.07M 0.02% 498
2025
Q4
$9.29M Sell
91,000
-32,000
-26% -$2.86M 0.05% 337
2025
Q3
$7.69M Buy
123,000
+83,000
+208% +$4.52M 0.04% 270
2025
Q2
$2.08M Buy
+40,000
New +$1.79M 0.02% 517
2024
Q2
Sell
-81,100
Closed -$1.67M 1569
2024
Q1
$1.67M Buy
+81,100
New +$1.74M 0.02% 651

Other funds holding GH

Jefferies Financial Group's GH Position: Q1 2026 in Review

Jefferies Financial Group reduced its Guardant Health (GH) stake by 70% in Q1 2026, selling an estimated $4.52M and leaving 18,879 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #685.

Jefferies Financial Group first reported a position in GH in Q3 2024 and has held it in 5 quarters since. The position peaked at $6.53M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Jefferies Financial Group held 18,879 shares of Guardant Health worth $1.74M as of Q1 2026.
  • Jefferies Financial Group sold 45,039 Guardant Health shares in Q1 2026, an estimated $4.52M.
  • Guardant Health made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #685 holding.
  • Jefferies Financial Group first reported a position in Guardant Health in Q3 2024 and has held it in 5 quarters since.
  • Jefferies Financial Group's Guardant Health position peaked at $6.53M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.